Liberty Biopharma (CVE:LTY) Stock Passes Above 50 Day Moving Average of $2.00

Liberty Biopharma Inc (CVE:LTYGet Rating)’s stock price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares traded.

Liberty Biopharma Price Performance

The company’s 50 day moving average is C$2.00 and its 200 day moving average is C$2.00. The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 8.19. The stock has a market capitalization of C$21.54 million and a price-to-earnings ratio of -12.66.

About Liberty Biopharma

(Get Rating)

Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.

Featured Stories

Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.